PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • Sustainability
  • Investor Relations
  • Newsroom

About Us

About PHC GroupCEO MessageMission, Vision & ValuesValue Creation PlanHistory LeadershipPHC Group by the Numbers

Group Companies

Ascensia LSI Medience Wemex Mediford Epredia PHCbi PHC IVD

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

Sustainability

Sustainability
  • CEO Message
  • Materiality
  • Sustainability Management
  • PHC GROUP Integrated Report
  • Stakeholder Engagement
  • Environment image
    Environment
  • Society image
    Social
  • Governance image
    Governance

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy
  • Business Risks

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials
  • Historical Financial Data
  • PHC GROUP Integrated Report
  • Mid-term Plan
  • Our Group Introduction

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Shareholder Newsletter
  • Stock Quotations
  • Analyst Coverage
IR News Financial Highlights IR Calendar Contact IR Disclaimer

Newsroom

NEWSROOM

NEWS

  • PHC Holdings Corporation
  • PHC Group Companies
CareersContact
JP

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • Ascensia Diabetes Care Holdings AG
  • PHC Corporation
  • LSI Medience Corporation
  • Wemex Corporation
  • Mediford Corporation
  • Epredia Holdings Ltd.
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • SciMed (ASIA) Pte Ltd
  • Amelieff Corporation
CareersContactJP
Newsroom > 2021 > Site Reopening in Response to Lifting of COVID-19 Imposed State of Emergency.

News


2021

AnnouncementJune 21

Site Reopening in Response to Lifting of COVID-19 Imposed State of Emergency.

Our sincere condolences to victims of COVID-19, and we hope for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals on the forefront to treat patients, and everyone helping to support the community infrastructure.

Responding to the Japanese Government’s decision to lift the state of emergency in nine prefectures excluding Okinawa, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be reopening its company sites from June 22. However, as we prioritize the safety of customers and employees, employees at the reopening sites will continue to work from home as standard practice, except in situations where working from the office is required. At other sites in Japan, employees will also continue to work from home as much as possible. When a customer visit is required, upon receipt of the customer’s consent, the visiting employee will strictly implement infection prevention measures such as temperature measurement, wearing of face masks, hand-washing, etc.

● Site reopening

PHC Holdings Corporation Shimbashi Headquarters
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
PHC Corporation Shimbashi Headquarters
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo

Osaka site
    Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka

Biomedical Business Unit
  ・Hokkaido Sales Office
    Address: Fukuyama Minami-Sanjo Building 6F, 10-1001-5 Minami-Sanjo Nishi, Chuo-ku, Sapporo City, Hokkaido
  ・Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo
  ・South Kanto Sales Office
    Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa
  ・Chubu Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: Nagoya Panasonic Building 6F, 1-23-30 Izumi, Higashi-ku, Nagoya City, Aichi
  ・Kinki Sales Office/Pharmacy System Sales Office/Delicart Sales Office
    Address: OAP Tower 16F, 1-8-30 Tenmabashi, Kita-ku, Osaka City, Osaka
  ・Chugoku Sales Office
    Address: Kureshin Hiroshima Building 10F, 2-6 Mikawa-cho, Naka-ku, Hiroshima City, Hiroshima
  ・Kyushu Sales Office/ Pharmacy System Sales Office
    Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka

Medical Information Systems Business Unit
  ・Customer Service Department, Field Engagement Promotion Group
    Address: Fukuyama Minami-Sanjo Building 6F, 10-1001-5 Minami-Sanjo Nishi, Chuo-ku, Sapporo City, Hokkaido
  ・Business Transformation Center
    Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo
  ・Omiya Office
    Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama
  ・Kyushu Sales Office
    Address: Riverain Center Building 11F, 3-1 Shimokawabata-machi, Hakata-ku, Fukuoka City, Fukuoka

Epredia Anatomical Pathology Business Unit
  ・Shinkoyasu Manufacturing Site
    Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa
  ・CS Repair Warehouse
    Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo

Shonan Health Innovation Park Office
    Address: Shonan Health Innovation Park BW3M-2320, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa

The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of infection, while working to ensure stable supply for customers and patients who rely on our products and services.

Media contact

Corporate Communications Dept.
PHC Holdings Corporation
+81-3-6778-5311

  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.